AGRIN ALS MARKER FÜR ENDOMETRIUMKARZINOM
European patent · EP3655778 · In force
Register entry
- Publication number
- EP3655778
- Application number
- EP18749741
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 20, 2018
- Published
- May 27, 2020
- Granted
- Jun 7, 2023
- Protection ends at the latest
- Jul 19, 2038
- Next annual fee due
- Jul 31, 2027
- IPC classes
- G01N 33/574 (2006.01)
- Priority
- EP 17382483 21.07.2017
- PCT application
- PCT/EP2018/069841 20.07.2018
- PCT publication
- WO2019/016400 24.01.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
- Aug 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.07.2025 → 31.07.2026
Published in Swissreg on 01.08.2025
- Aug 1, 2024
Change
Published in Swissreg on 01.08.2024
- Apr 24, 2024
Change
Published in Swissreg on 24.04.2024
- Apr 17, 2024
Change
Published in Swissreg on 17.04.2024
- Aug 15, 2023
Agent entered
- Representative
- BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 15.08.2023
- Aug 1, 2023
Change
Published in Swissreg on 01.08.2023
- Jun 7, 2023
Granted
Published in Swissreg on 07.06.2023
Parties
Inventor
08020 Barcelona, ES
CH-2534 Orvin
08172 Sant Cugat Del Vallès, ES
09002 Burgos, ES
L-8010 Strassen, LU
08028 Barcelona, ES
08348 Cabrils, ES
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.